Ocular surface squamous neoplasia
diseaseOn this page
Summary
Ocular surface squamous neoplasia (MONDO:0971056) is a disease and 2 clinical trials. A subtype of squamous cell neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (United States) [Orphanet-validated]
- Clinical trials: 2
Clinical features
Epidemiology
Prevalence records
1 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | <1 / 1 000 000 | 0.03 | United States | Validated |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | ocular surface squamous neoplasia |
| Mondo ID | MONDO:0971056 |
| Orphanet | 659744 |
| UMLS | C4761284 |
| MedGen | 1787978 |
| GARD | 0027162 |
| Is cancer (heuristic) | no |
Disease family
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › squamous cell neoplasm › ocular surface squamous neoplasia
Related subtypes (6): vaginal squamous tumor, vulvar squamous neoplasm, ovarian squamous cell neoplasm, squamous cell carcinoma, craniopharyngioma, squamous cell intraepithelial neoplasia
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 2.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 2 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT04704648 | Not specified | RECRUITING | Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa |
| NCT05797415 | Not specified | RECRUITING | Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.